diff --git a/app/components/PackagingShipping/DNASamples.jsx b/app/components/PackagingShipping/DNASamples.jsx index 8c61468..9d1c536 100644 --- a/app/components/PackagingShipping/DNASamples.jsx +++ b/app/components/PackagingShipping/DNASamples.jsx @@ -5,7 +5,7 @@ const DNASamples = () => { return (
-

Shipping of DNA Samples

+

Shipping of DNA Samples

diff --git a/app/components/PackagingShipping/GeneralGuidelines.jsx b/app/components/PackagingShipping/GeneralGuidelines.jsx index 32bd1d9..c428d3f 100644 --- a/app/components/PackagingShipping/GeneralGuidelines.jsx +++ b/app/components/PackagingShipping/GeneralGuidelines.jsx @@ -4,7 +4,7 @@ const GeneralGuidelines = () => { return (
-

General Guidelines

+

General Guidelines

diff --git a/app/components/PackagingShipping/PackagingGuideline.jsx b/app/components/PackagingShipping/PackagingGuideline.jsx index 6492904..0f3c7f8 100644 --- a/app/components/PackagingShipping/PackagingGuideline.jsx +++ b/app/components/PackagingShipping/PackagingGuideline.jsx @@ -4,7 +4,7 @@ const PackagingGuideline = () => { return (
-

Packaging Guideline

+

Packaging Guideline

diff --git a/app/components/PackagingShipping/RNASamples.jsx b/app/components/PackagingShipping/RNASamples.jsx index 73ad98d..ba730bb 100644 --- a/app/components/PackagingShipping/RNASamples.jsx +++ b/app/components/PackagingShipping/RNASamples.jsx @@ -4,40 +4,50 @@ const RNASamples = () => { return (
-

Shipping of RNA Samples

+

Shipping of RNA Samples

-

- Bioanalyzer QC report is advised to be shared from the client's end, in the - absence of which an agarose Gel Electrophoresis and Nanodrop quantification - to confirm the integrity of RNA must be shared. Samples with A260/280 ratio - values of ~1.8 are considered "pure" for DNA and will be accepted for - processing further. -

- -

- We require Bioanalyzer traces (or similar) for all customer-submitted - sequencing libraries and total RNA samples. If traces are not provided, we - will perform Bioanalyzer QC for an additional fee. If you can supply traces, - please include them into the shipment in hard copy. Also, ensure that your - samples meet the specified sample or library requirements [LINK]. -

- -

- For large-scale projects, RNA samples can be submitted in strip tubes with - individually attached RNase-free caps. Pack the strips into racks (e.g., - empty pipet tip boxes) and ensure they are secured to prevent movement - during transport. -

- -

- RNA, cells, bacteria, and frozen tissue samples should be stored in liquid - nitrogen for rapid freezing and then transported with dry ice. For longer - shipments, RNA samples can also be successfully shipped dry at room - temperature after LiCl/ethanol precipitation and ethanol washes; make sure - to mark the pellet's position on the tubes. -

+
    +
  • + + Bioanalyzer QC report is advised to be shared from the client's end, in the + absence of which an agarose Gel Electrophoresis and Nanodrop quantification + to confirm the integrity of RNA must be shared. Samples with A260/280 ratio + values of ~1.8 are considered "pure" for DNA and will be accepted for + processing further. + +
    • + +
  • + + We require Bioanalyzer traces (or similar) for all customer-submitted + sequencing libraries and total RNA samples. If traces are not provided, we + will perform Bioanalyzer QC for an additional fee. If you can supply traces, + please include them into the shipment in hard copy. Also, ensure that your + samples meet the specified sample or library requirements [LINK]. + +
    • + +
  • + + For large-scale projects, RNA samples can be submitted in strip tubes with + individually attached RNase-free caps. Pack the strips into racks (e.g., + empty pipet tip boxes) and ensure they are secured to prevent movement + during transport. + +
    • + +
  • + + RNA, cells, bacteria, and frozen tissue samples should be stored in liquid + nitrogen for rapid freezing and then transported with dry ice. For longer + shipments, RNA samples can also be successfully shipped dry at room + temperature after LiCl/ethanol precipitation and ethanol washes; make sure + to mark the pellet's position on the tubes. + +
    • +
); diff --git a/app/components/PackagingShipping/ShippingSchedule.jsx b/app/components/PackagingShipping/ShippingSchedule.jsx index 28579b2..55f0240 100644 --- a/app/components/PackagingShipping/ShippingSchedule.jsx +++ b/app/components/PackagingShipping/ShippingSchedule.jsx @@ -4,7 +4,7 @@ const ShippingSchedule = () => { return (
-

Shipping Schedule and Address

+

Shipping Schedule and Address

diff --git a/app/components/PackagingShipping/ShippingTemperatureTable.jsx b/app/components/PackagingShipping/ShippingTemperatureTable.jsx index 1b8b6b2..fbc7270 100644 --- a/app/components/PackagingShipping/ShippingTemperatureTable.jsx +++ b/app/components/PackagingShipping/ShippingTemperatureTable.jsx @@ -129,7 +129,7 @@ const ShippingTemperatureTable = () => { return (
-

Shipping Temperature and Condition

+

Shipping Temperature and Condition

diff --git a/app/components/SampleGuideline/ContentSection.jsx b/app/components/SampleGuideline/ContentSection.jsx index 9165d3c..76a8022 100644 --- a/app/components/SampleGuideline/ContentSection.jsx +++ b/app/components/SampleGuideline/ContentSection.jsx @@ -18,7 +18,7 @@ const ContentSection = () => { return (
-
+
{/* LEFT SIDEBAR */}
diff --git a/app/components/SampleGuideline/GeneralGuidelines.jsx b/app/components/SampleGuideline/GeneralGuidelines.jsx index 7724a93..2ab3934 100644 --- a/app/components/SampleGuideline/GeneralGuidelines.jsx +++ b/app/components/SampleGuideline/GeneralGuidelines.jsx @@ -4,46 +4,58 @@ const GeneralGuidelines = () => { return (
-

General Guidelines

+

General Guidelines

-
    -
  • - Please complete the Sample Initiation Form (SIF), ensuring that the - sample names on the form match the labels on the sample tubes. We also - request that you send an electronic copy of the form and any required QC - data via email. +
      +
    • + + Please complete the Sample Initiation Form (SIF), ensuring that the + sample names on the form match the labels on the sample tubes. We also + request that you send an electronic copy of the form and any required QC + data via email. +
      • -
    • - Each tube should be labeled on the lid with a maximum of 4-6 - alphanumeric characters (e.g., 4B0001). Use a black permanent marker to - write sample names on the top and side of each tube. Avoid writing - directly on the tube wall or cover with an oil pen. +
    • + + Each tube should be labeled on the lid with a maximum of 4-6 + alphanumeric characters (e.g., 4B0001). Use a black permanent marker to + write sample names on the top and side of each tube. Avoid writing + directly on the tube wall or cover with an oil pen. +
      • -
    • - DNA can be submitted in DNase-free water, Elution Buffer, or 10mM Tris - pH 8.0. DNA samples should have an OD260/280 ratio as close to 1.8~2.0 - as possible. All DNA should be RNase-treated and free from degradation - or contamination. Ship with ice packs. The total amount of DNA required - depends on the specific application. +
    • + + DNA can be submitted in DNase-free water, Elution Buffer, or 10mM Tris + pH 8.0. DNA samples should have an OD260/280 ratio as close to 1.8~2.0 + as possible. All DNA should be RNase-treated and free from degradation + or contamination. Ship with ice packs. The total amount of DNA required + depends on the specific application. +
      • -
    • - RNA can be submitted in RNase-free water, RNA Stabilization Reagent, or - 10mM Tris pH 8.0. All total RNA samples should be DNA-free, with an OD - A260/A280 ratio ≥ 1.8, A260/230 ratio ≥ 1.8, and a RIN ≥ 6. Ship with - dry ice. The total amount of RNA required depends on the specific - application. For Long Read Sequencing, RNA samples should have a RIN ≥ - 8. +
    • + + RNA can be submitted in RNase-free water, RNA Stabilization Reagent, or + 10mM Tris pH 8.0. All total RNA samples should be DNA-free, with an OD + A260/A280 ratio ≥ 1.8, A260/230 ratio ≥ 1.8, and a RIN ≥ 6. Ship with + dry ice. The total amount of RNA required depends on the specific + application. For Long Read Sequencing, RNA samples should have a RIN ≥ + 8. +
      • -
    • - The listed concentrations should be determined by fluorometry (e.g., - PicoGreen/Qubit/RiboGreen). If using spectrophotometry (e.g., Nanodrop), - increase concentrations by approximately twofold. +
    • + + The listed concentrations should be determined by fluorometry (e.g., + PicoGreen/Qubit/RiboGreen). If using spectrophotometry (e.g., Nanodrop), + increase concentrations by approximately twofold. +
      • -
    • - The quality inspection method for the sizes and concentrations of the - Ready To Run Library is Qubit and Agilent Bioanalyzer. +
    • + + The quality inspection method for the sizes and concentrations of the + Ready To Run Library is Qubit and Agilent Bioanalyzer. +
diff --git a/app/components/SampleGuideline/IntroSection.jsx b/app/components/SampleGuideline/IntroSection.jsx index 5db1a60..1a3fb95 100644 --- a/app/components/SampleGuideline/IntroSection.jsx +++ b/app/components/SampleGuideline/IntroSection.jsx @@ -2,11 +2,11 @@ import React from 'react'; const IntroSection = () => { return ( -
-
-
-
-

+

+
+
+
+

We humbly offer a wide range of services, including genomics, transcriptomics, metagenomics, epigenomics, single-cell sequencing, genotyping, microarray, bioinformatics, and more. To help us deliver the best results for you, we request you to diff --git a/app/components/SampleGuideline/SearchSampleRequirements.jsx b/app/components/SampleGuideline/SearchSampleRequirements.jsx index 3dbcee9..8e9cf87 100644 --- a/app/components/SampleGuideline/SearchSampleRequirements.jsx +++ b/app/components/SampleGuideline/SearchSampleRequirements.jsx @@ -67,7 +67,7 @@ const SearchSampleRequirements = () => { return (

-

Search Sample Requirements

+

Search Sample Requirements

{ return (
-
+
{/* Main Title */}
-

+

Welcome to Our Online Submission Portal!

diff --git a/app/components/SampleInitiation/ProcessSteps.jsx b/app/components/SampleInitiation/ProcessSteps.jsx index 52d2f0d..88c5798 100644 --- a/app/components/SampleInitiation/ProcessSteps.jsx +++ b/app/components/SampleInitiation/ProcessSteps.jsx @@ -46,8 +46,10 @@ const ProcessSteps = () => {
    {step.items.map((item, index) => ( -
  • - {item} +
  • + + {item} +
    • ))}
diff --git a/app/components/SampleInitiation/SampleInitiationPage.jsx b/app/components/SampleInitiation/SampleInitiationPage.jsx index 6887741..29bdbcc 100644 --- a/app/components/SampleInitiation/SampleInitiationPage.jsx +++ b/app/components/SampleInitiation/SampleInitiationPage.jsx @@ -1,14 +1,14 @@ import React from 'react'; import PageTitle from './PageTitle'; import ProcessSection from './ProcessSection'; -import ContactNote from './ContactNote'; +// import ContactNote from './ContactNote'; const SampleInitiationPage = () => { return (
- + {/* */}
); }; diff --git a/app/dna-sequencing/components/AboutDNA.jsx b/app/dna-sequencing/components/AboutDNA.jsx index 2ed1b6c..41d137c 100644 --- a/app/dna-sequencing/components/AboutDNA.jsx +++ b/app/dna-sequencing/components/AboutDNA.jsx @@ -4,24 +4,21 @@ import React from 'react'; const AboutDNA = () => { return (
-
-

+
+

About DNA Sequencing

Exploring Life's Blueprint with Every Sequence

-
+

DNA sequencing is a method used to determine the precise order of nucleotides (adenine, thymine, cytosine, and guanine) in a DNA molecule. This information is critical for understanding genetic information, mutations, and their roles in disease, evolution, and various biological processes.

-

- Different DNA sequencing approaches using Next Generation sequencing are listed below: -

diff --git a/app/dna-sequencing/components/DNATable.jsx b/app/dna-sequencing/components/DNATable.jsx index e1155ba..25da8db 100644 --- a/app/dna-sequencing/components/DNATable.jsx +++ b/app/dna-sequencing/components/DNATable.jsx @@ -115,17 +115,17 @@ const DNATable = () => { ]; return ( -
-
-

DNA Sequencing Approaches

+
+
+

DNA Sequencing Approaches

Different DNA sequencing approaches and their applications are summarized below:

-
- +
+
diff --git a/app/health/Components/ClinicalAreas.jsx b/app/health/Components/ClinicalAreas.jsx index 0b9ee19..9a52c1a 100644 --- a/app/health/Components/ClinicalAreas.jsx +++ b/app/health/Components/ClinicalAreas.jsx @@ -6,12 +6,12 @@ export default function ClinicalAreas() { return (
{/* Heading */} -

+

Precise Solutions for Clinical Areas

{/* Subtext */} -

+

Empowering you with precise, tailored approaches to diagnostics and care — addressing the unique needs of each clinical area to improve patient outcomes.

diff --git a/app/health/Components/HealthIntro.jsx b/app/health/Components/HealthIntro.jsx index b014870..4c8e909 100644 --- a/app/health/Components/HealthIntro.jsx +++ b/app/health/Components/HealthIntro.jsx @@ -4,46 +4,40 @@ import Link from "next/link"; export default function AboutHealth() { return ( -
- {/* Title */} -

About Health

- - {/* Intro Section */} -
- {/* Left Content */} -
-

- At Operify Health, we believe every patient deserves answers that are not only - accurate — but actionable. By harnessing the power of Next Generation Sequencing - (NGS), we transform patient samples into rich genomic insights that enable - clinicians and oncologists to make informed, personalized decisions. From rare - genetic disorders to complex oncological cases, our solutions help uncover what - traditional diagnostics often miss. -

-

- Our strength lies in our multidisciplinary team of researchers, bioinformaticians, - and data scientists who use custom-built algorithms and cutting-edge analytics to - interpret genetic data with unmatched depth. Backed by curated scientific evidence - and real-world clinical findings, we deliver recommendations that are current, - relevant, and patient-focused. -

-

- With every genome we decode, we move closer to truly personalized medicine — - bridging data and care, science and life. -

-
- - {/* Right Image */} -
- +
+
+
+
+
    +
  • + + At Operify Health, we believe every patient deserves answers that are not only + accurate — but actionable. By harnessing the power of Next Generation Sequencing + (NGS), we transform patient samples into rich genomic insights that enable + clinicians and oncologists to make informed, personalized decisions. From rare + genetic disorders to complex oncological cases, our solutions help uncover what + traditional diagnostics often miss. + +
    • +
  • + + Our strength lies in our multidisciplinary team of researchers, bioinformaticians, + and data scientists who use custom-built algorithms and cutting-edge analytics to + interpret genetic data with unmatched depth. Backed by curated scientific evidence + and real-world clinical findings, we deliver recommendations that are current, + relevant, and patient-focused. + +
    • +
  • + + With every genome we decode, we move closer to truly personalized medicine — + bridging data and care, science and life. + +
    • +
+
-
+ ); } \ No newline at end of file diff --git a/app/health/Components/HealthTitle.jsx b/app/health/Components/HealthTitle.jsx index 74cc12e..85d8334 100644 --- a/app/health/Components/HealthTitle.jsx +++ b/app/health/Components/HealthTitle.jsx @@ -3,7 +3,7 @@ import React from 'react'; const HealthTitle = () => { return (
{/* Breadcrumb */} diff --git a/app/health/components/ClinicalAreas.jsx b/app/health/components/ClinicalAreas.jsx index 0b9ee19..9a52c1a 100644 --- a/app/health/components/ClinicalAreas.jsx +++ b/app/health/components/ClinicalAreas.jsx @@ -6,12 +6,12 @@ export default function ClinicalAreas() { return (
{/* Heading */} -

+

Precise Solutions for Clinical Areas

{/* Subtext */} -

+

Empowering you with precise, tailored approaches to diagnostics and care — addressing the unique needs of each clinical area to improve patient outcomes.

diff --git a/app/health/components/HealthIntro.jsx b/app/health/components/HealthIntro.jsx index b014870..4c8e909 100644 --- a/app/health/components/HealthIntro.jsx +++ b/app/health/components/HealthIntro.jsx @@ -4,46 +4,40 @@ import Link from "next/link"; export default function AboutHealth() { return ( -
- {/* Title */} -

About Health

- - {/* Intro Section */} -
- {/* Left Content */} -
-

- At Operify Health, we believe every patient deserves answers that are not only - accurate — but actionable. By harnessing the power of Next Generation Sequencing - (NGS), we transform patient samples into rich genomic insights that enable - clinicians and oncologists to make informed, personalized decisions. From rare - genetic disorders to complex oncological cases, our solutions help uncover what - traditional diagnostics often miss. -

-

- Our strength lies in our multidisciplinary team of researchers, bioinformaticians, - and data scientists who use custom-built algorithms and cutting-edge analytics to - interpret genetic data with unmatched depth. Backed by curated scientific evidence - and real-world clinical findings, we deliver recommendations that are current, - relevant, and patient-focused. -

-

- With every genome we decode, we move closer to truly personalized medicine — - bridging data and care, science and life. -

-
- - {/* Right Image */} -
- +
+
+
+
+
    +
  • + + At Operify Health, we believe every patient deserves answers that are not only + accurate — but actionable. By harnessing the power of Next Generation Sequencing + (NGS), we transform patient samples into rich genomic insights that enable + clinicians and oncologists to make informed, personalized decisions. From rare + genetic disorders to complex oncological cases, our solutions help uncover what + traditional diagnostics often miss. + +
    • +
  • + + Our strength lies in our multidisciplinary team of researchers, bioinformaticians, + and data scientists who use custom-built algorithms and cutting-edge analytics to + interpret genetic data with unmatched depth. Backed by curated scientific evidence + and real-world clinical findings, we deliver recommendations that are current, + relevant, and patient-focused. + +
    • +
  • + + With every genome we decode, we move closer to truly personalized medicine — + bridging data and care, science and life. + +
    • +
+
-
+
); } \ No newline at end of file diff --git a/app/health/components/HealthTitle.jsx b/app/health/components/HealthTitle.jsx index 74cc12e..85d8334 100644 --- a/app/health/components/HealthTitle.jsx +++ b/app/health/components/HealthTitle.jsx @@ -3,7 +3,7 @@ import React from 'react'; const HealthTitle = () => { return (
{/* Breadcrumb */} diff --git a/app/health/oncology/Components/HereditaryCancerPanel.jsx b/app/health/oncology/Components/HereditaryCancerPanel.jsx index 1f0f1cd..b21a77c 100644 --- a/app/health/oncology/Components/HereditaryCancerPanel.jsx +++ b/app/health/oncology/Components/HereditaryCancerPanel.jsx @@ -9,29 +9,32 @@ export default function HereditaryCancerPanel() { { title: "Genetic Counseling Support", desc: "Optional access to pre- and post-test counseling for patient education and informed decision-making." } ]; + const points = [ + "About 5-10% of all cancers are linked to inherited genetic mutations, often going undetected until late stages or after multiple family members are affected.", + "The Operify Hereditary Cancer Panel screens key high- and moderate-risk genes associated with hereditary cancer syndromes like HBOC, Lynch Syndrome (LS), Li Fraumeni Syndrome (LFS), Familial Adenomatous Polyposis (FAP), Cowden Syndrome (CS), Peutz-Jeghers Syndrome (PJS), Neurofibromatosis (NF) etc.", + "Early identification of germline mutations enables proactive clinical decisions, including risk-reducing strategies, targeted surveillance, and family cascade testing.", + "Studies show that genetic testing in hereditary cancer cases improves outcomes and informs care for both patients and at-risk relatives." + ]; + return ( -
-

Operify Hereditary Cancer Panel

+
+

Operify Hereditary Cancer Panel

-

- About 5-10% of all cancers are linked to inherited genetic mutations, often going - undetected until late stages or after multiple family members are affected. -

-

- The Operify Hereditary Cancer Panel screens key high- and moderate-risk genes associated - with hereditary cancer syndromes like HBOC, Lynch Syndrome (LS), Li Fraumeni Syndrome (LFS), - Familial Adenomatous Polyposis (FAP), Cowden Syndrome (CS), Peutz-Jeghers Syndrome (PJS), - Neurofibromatosis (NF) etc. -

-

- Early identification of germline mutations enables proactive clinical decisions, including - risk-reducing strategies, targeted surveillance, and family cascade testing. -

-

- Studies show that genetic testing in hereditary cancer cases improves outcomes and informs - care for both patients and at-risk relatives. -

+
    + {points.map((point, idx) => ( +
  • + +

    + {idx === 0 ? "About 5-10% of all cancers are linked to inherited genetic mutations" : ""} + {idx === 0 ? ", often going undetected until late stages or after multiple family members are affected." : point} +

    +
    • + ))} +

Key Features

@@ -45,7 +48,7 @@ export default function HereditaryCancerPanel() {
{features.map((feature, idx) => ( - + diff --git a/app/health/oncology/Components/OncologyIntro.jsx b/app/health/oncology/Components/OncologyIntro.jsx index 448bda3..7d1b1a3 100644 --- a/app/health/oncology/Components/OncologyIntro.jsx +++ b/app/health/oncology/Components/OncologyIntro.jsx @@ -1,31 +1,52 @@ export default function OncologyIntro() { return ( -
-

Oncology

-

Turning Complexity into Clarity

-

- Cancer is not a single disease—it's a highly complex and dynamic group of disorders, - often driven by a multitude of genomic alterations. Despite advancements in treatment, - many patients still face uncertainty due to incomplete or delayed molecular diagnoses. -

-

- At Operify Health, we recognize that behind every tumor is a unique genetic story waiting - to be told. Our precision oncology solutions utilize high-throughput Next Generation - Sequencing (NGS) to analyze both somatic and germline mutations—providing clinicians - with actionable insights that inform targeted therapies, immunotherapy decisions, and - hereditary cancer risk assessments. -

-

- This genomic-driven approach is especially critical in advanced and treatment-resistant - cancers, where conventional methods often fall short. Studies have shown that integrating - broad-panel NGS into cancer care can impact clinical decision-making in up to 30% of cases, - leading to more personalized and effective treatment strategies. -

-

- By combining cutting-edge sequencing, advanced bioinformatics, and curated clinical evidence, - Operify Health empowers oncologists to move from uncertainty to precision—ensuring every cancer - patient's care is as individualized as their diagnosis. -

+
+
+
+
+

+ Turning Complexity into Clarity +

+
    +
  • +
    + + Cancer is not a single disease—it's a highly complex and dynamic group of disorders, + often driven by a multitude of genomic alterations. Despite advancements in treatment, + many patients still face uncertainty due to incomplete or delayed molecular diagnoses. + +
    • +
  • +
    + + At Operify Health, we recognize that behind every tumor is a unique genetic story waiting + to be told. Our precision oncology solutions utilize high-throughput Next Generation + Sequencing (NGS) to analyze both somatic and germline mutations—providing clinicians + with actionable insights that inform targeted therapies, immunotherapy decisions, and + hereditary cancer risk assessments. + +
    • +
  • +
    + + This genomic-driven approach is especially critical in advanced and treatment-resistant + cancers, where conventional methods often fall short. Studies have shown that integrating + broad-panel NGS into cancer care can impact clinical decision-making in up to 30% of cases, + leading to more personalized and effective treatment strategies. + +
    • +
  • +
    + + By combining cutting-edge sequencing, advanced bioinformatics, and curated clinical evidence, + Operify Health empowers oncologists to move from uncertainty to precision—ensuring every cancer + patient's care is as individualized as their diagnosis. + +
    • +
+
+
+
); } \ No newline at end of file diff --git a/app/health/oncology/components/HereditaryCancerPanel.jsx b/app/health/oncology/components/HereditaryCancerPanel.jsx index 1f0f1cd..b21a77c 100644 --- a/app/health/oncology/components/HereditaryCancerPanel.jsx +++ b/app/health/oncology/components/HereditaryCancerPanel.jsx @@ -9,29 +9,32 @@ export default function HereditaryCancerPanel() { { title: "Genetic Counseling Support", desc: "Optional access to pre- and post-test counseling for patient education and informed decision-making." } ]; + const points = [ + "About 5-10% of all cancers are linked to inherited genetic mutations, often going undetected until late stages or after multiple family members are affected.", + "The Operify Hereditary Cancer Panel screens key high- and moderate-risk genes associated with hereditary cancer syndromes like HBOC, Lynch Syndrome (LS), Li Fraumeni Syndrome (LFS), Familial Adenomatous Polyposis (FAP), Cowden Syndrome (CS), Peutz-Jeghers Syndrome (PJS), Neurofibromatosis (NF) etc.", + "Early identification of germline mutations enables proactive clinical decisions, including risk-reducing strategies, targeted surveillance, and family cascade testing.", + "Studies show that genetic testing in hereditary cancer cases improves outcomes and informs care for both patients and at-risk relatives." + ]; + return ( -
-

Operify Hereditary Cancer Panel

+
+

Operify Hereditary Cancer Panel

-

- About 5-10% of all cancers are linked to inherited genetic mutations, often going - undetected until late stages or after multiple family members are affected. -

-

- The Operify Hereditary Cancer Panel screens key high- and moderate-risk genes associated - with hereditary cancer syndromes like HBOC, Lynch Syndrome (LS), Li Fraumeni Syndrome (LFS), - Familial Adenomatous Polyposis (FAP), Cowden Syndrome (CS), Peutz-Jeghers Syndrome (PJS), - Neurofibromatosis (NF) etc. -

-

- Early identification of germline mutations enables proactive clinical decisions, including - risk-reducing strategies, targeted surveillance, and family cascade testing. -

-

- Studies show that genetic testing in hereditary cancer cases improves outcomes and informs - care for both patients and at-risk relatives. -

+
    + {points.map((point, idx) => ( +
  • + +

    + {idx === 0 ? "About 5-10% of all cancers are linked to inherited genetic mutations" : ""} + {idx === 0 ? ", often going undetected until late stages or after multiple family members are affected." : point} +

    +
    • + ))} +

Key Features

@@ -45,7 +48,7 @@ export default function HereditaryCancerPanel() {
{features.map((feature, idx) => ( - + diff --git a/app/health/oncology/components/OncologyIntro.jsx b/app/health/oncology/components/OncologyIntro.jsx index 448bda3..7d1b1a3 100644 --- a/app/health/oncology/components/OncologyIntro.jsx +++ b/app/health/oncology/components/OncologyIntro.jsx @@ -1,31 +1,52 @@ export default function OncologyIntro() { return ( -
-

Oncology

-

Turning Complexity into Clarity

-

- Cancer is not a single disease—it's a highly complex and dynamic group of disorders, - often driven by a multitude of genomic alterations. Despite advancements in treatment, - many patients still face uncertainty due to incomplete or delayed molecular diagnoses. -

-

- At Operify Health, we recognize that behind every tumor is a unique genetic story waiting - to be told. Our precision oncology solutions utilize high-throughput Next Generation - Sequencing (NGS) to analyze both somatic and germline mutations—providing clinicians - with actionable insights that inform targeted therapies, immunotherapy decisions, and - hereditary cancer risk assessments. -

-

- This genomic-driven approach is especially critical in advanced and treatment-resistant - cancers, where conventional methods often fall short. Studies have shown that integrating - broad-panel NGS into cancer care can impact clinical decision-making in up to 30% of cases, - leading to more personalized and effective treatment strategies. -

-

- By combining cutting-edge sequencing, advanced bioinformatics, and curated clinical evidence, - Operify Health empowers oncologists to move from uncertainty to precision—ensuring every cancer - patient's care is as individualized as their diagnosis. -

+
+
+
+
+

+ Turning Complexity into Clarity +

+
    +
  • +
    + + Cancer is not a single disease—it's a highly complex and dynamic group of disorders, + often driven by a multitude of genomic alterations. Despite advancements in treatment, + many patients still face uncertainty due to incomplete or delayed molecular diagnoses. + +
    • +
  • +
    + + At Operify Health, we recognize that behind every tumor is a unique genetic story waiting + to be told. Our precision oncology solutions utilize high-throughput Next Generation + Sequencing (NGS) to analyze both somatic and germline mutations—providing clinicians + with actionable insights that inform targeted therapies, immunotherapy decisions, and + hereditary cancer risk assessments. + +
    • +
  • +
    + + This genomic-driven approach is especially critical in advanced and treatment-resistant + cancers, where conventional methods often fall short. Studies have shown that integrating + broad-panel NGS into cancer care can impact clinical decision-making in up to 30% of cases, + leading to more personalized and effective treatment strategies. + +
    • +
  • +
    + + By combining cutting-edge sequencing, advanced bioinformatics, and curated clinical evidence, + Operify Health empowers oncologists to move from uncertainty to precision—ensuring every cancer + patient's care is as individualized as their diagnosis. + +
    • +
+
+
+
); } \ No newline at end of file diff --git a/app/health/rare-disorders/components/ClinicalAreasGrid.jsx b/app/health/rare-disorders/components/ClinicalAreasGrid.jsx index 0752080..a9d1449 100644 --- a/app/health/rare-disorders/components/ClinicalAreasGrid.jsx +++ b/app/health/rare-disorders/components/ClinicalAreasGrid.jsx @@ -21,8 +21,8 @@ export default function ClinicalAreasGrid() { ]; return ( -
-

Clinical Areas

+
+

Clinical Areas

{areas.map((area, idx) => (
-

Operify Exome

+
+

Operify Exome

-

- Whole Exome Sequencing (WES) targets the protein-coding regions of the genome, where most - disease-causing mutations are found. -

-

- With over 7,000 rare diseases identified—80% of which have a genetic basis—WES offers a - powerful approach to uncover their causes. -

-

- Traditional diagnostic methods can be slow, costly, and inconclusive; WES streamlines the - process by delivering broad genetic insights in a single test. -

-

- Operify Exome enhances WES by combining comprehensive coverage with advanced interpretation, - improving diagnostic yield and patient outcomes. -

+
    + {points.map((point, idx) => ( +
  • + +

    + {point} +

    +
    • + ))} +
-

Key Features

+

Key Features

@@ -146,7 +146,7 @@ const DNATable = () => { {sequencingData.map((row, index) => (
- + {row.approach.name}
{feature.title} {feature.desc}
{feature.title} {feature.desc}
diff --git a/app/health/rare-disorders/components/OperifyExomeMito.jsx b/app/health/rare-disorders/components/OperifyExomeMito.jsx index 08f42a7..c941f53 100644 --- a/app/health/rare-disorders/components/OperifyExomeMito.jsx +++ b/app/health/rare-disorders/components/OperifyExomeMito.jsx @@ -14,52 +14,48 @@ export default function OperifyExomeMito() { { genome: "Mitochondrial genome", coverage: "37 genes" } ]; + const points = [ + "The Operify ExomeMito Panel offers a unified solution by integrating whole exome sequencing with complete mitochondrial genome analysis—addressing both nuclear and mitochondrial causes of disease.", + "This combined approach is especially valuable in diagnosing complex, multisystemic, and rare disorders, where variants may exist across both genomes.", + "Mitochondrial disorders, though individually rare, are clinically significant, affecting approximately 1 in 5,000 individuals and often missed in standard testing.", + "Studies show that adding mitochondrial sequencing to exome testing increases diagnostic yield by up to 20%, offering greater clarity and clinical confidence. (PMID: 30369941)", + "While screening for rare genetic disorders, it's essential not to overlook the rarest among them-mitochondrial disorders, which occur in approximately 1 in 5,000 individuals. Although individually rare, their cumulative impact is significant in the context of rare disease diagnostics. Multiple studies have demonstrated a substantial increase in diagnostic yield—up to 20%—when mitochondrial genome sequencing is performed alongside whole exome sequencing. Reference: PMID: 30369941" + ]; + return ( -
-

Operify ExomeMito

+
+

Operify ExomeMito

Boost diagnostic yield with Exome + Mito Sequencing

-
-

- The Operify ExomeMito Panel offers a unified solution by integrating whole exome sequencing - with complete mitochondrial genome analysis—addressing both nuclear and mitochondrial causes - of disease. -

-

- This combined approach is especially valuable in diagnosing complex, multisystemic, and rare - disorders, where variants may exist across both genomes. -

-

- Mitochondrial disorders, though individually rare, are clinically significant, affecting - approximately 1 in 5,000 individuals and often missed in standard testing. -

-

- Studies show that adding mitochondrial sequencing to exome testing increases diagnostic - yield by up to 20%, offering greater clarity and clinical confidence. (PMID: 30369941) -

-

- While screening for rare genetic disorders, it's essential not to overlook the rarest among - them-mitochondrial disorders, which occur in approximately 1 in 5,000 individuals. Although - individually rare, their cumulative impact is significant in the context of rare disease - diagnostics. Multiple studies have demonstrated a substantial increase in diagnostic yield—up - to 20%—when mitochondrial genome sequencing is performed alongside whole exome sequencing. - Reference: PMID: 30369941 -

+
+
    + {points.map((point, idx) => ( +
  • + +

    + {point} +

    +
    • + ))} +
-

Genome Coverage

+

Genome Coverage

- - - + + + {genomeCoverage.map((item, idx) => ( - + @@ -69,18 +65,18 @@ export default function OperifyExomeMito() { -

Key Features

+

Key Features

GenomeCoverage
GenomeCoverage
{item.genome} {item.coverage}
- - - + + + {features.map((feature, idx) => ( - + diff --git a/app/health/rare-disorders/components/RareIntro.jsx b/app/health/rare-disorders/components/RareIntro.jsx index 2e2cf9f..efcaeda 100644 --- a/app/health/rare-disorders/components/RareIntro.jsx +++ b/app/health/rare-disorders/components/RareIntro.jsx @@ -1,18 +1,33 @@ export default function RareIntro() { return ( -
-

Rare Disorders

-

Transforming Delays into Diagnoses

-

- There are over 7,000 identified rare diseases, many of which begin in childhood—and - nearly 80% have a genetic cause. Yet, the average time to diagnose a rare disorder is - still 4.8 years, with some cases taking up to 20 years. -

-

- At Operify Health, we leverage advanced Next Generation Sequencing (NGS) and proprietary - bioinformatics to deliver rapid, reliable insights—helping reduce the diagnostic journey - from years to days. -

+
+
+
+
+

+ Transforming Delays into Diagnoses +

+
    +
  • +
    + + There are over 7,000 identified rare diseases, many of which begin in childhood—and + nearly 80% have a genetic cause. Yet, the average time to diagnose a rare disorder is + still 4.8 years, with some cases taking up to 20 years. + +
    • +
  • +
    + + At Operify Health, we leverage advanced Next Generation Sequencing (NGS) and proprietary + bioinformatics to deliver rapid, reliable insights—helping reduce the diagnostic journey + from years to days. + +
    • +
+
+
+
); } \ No newline at end of file diff --git a/app/health/rare-disorders/components/SampleRequirements.jsx b/app/health/rare-disorders/components/SampleRequirements.jsx index 5045f1e..5dc3bf9 100644 --- a/app/health/rare-disorders/components/SampleRequirements.jsx +++ b/app/health/rare-disorders/components/SampleRequirements.jsx @@ -1,36 +1,49 @@ -export default function SampleRequirements({ title, items }) { - return ( -
-
-

{title} Sample Requirements

- -
- {/* Turnaround Time */} -
-
- - - -
-
-

Turnaround Time

-

21 Days

-
-
+import Image from "next/image"; - {/* Sample Requirement */} -
-
- - - -
-
-

Sample Requirement

-

Blood/Saliva/Cheek Swab/Genomic DNA/Dry Blood Spot

+export default function SampleRequirements({ title, items }) { + const requirements = [ + { + icon: "/images/icons/clock.png", // Replace with your actual icon path + title: "Turnaround Time", + description: "21 Days" + }, + { + icon: "/images/icons/sample.png", // Replace with your actual icon path + title: "Sample Requirement", + description: "Blood/Saliva/Cheek Swab/Genomic DNA/Dry Blood Spot" + } + ]; + + return ( +
+

{title} Sample Requirements

+ +
+ {requirements.map((req, idx) => ( +
+
+
+ +
+
+

{req.title}

+

+ {req.description} +

+
-
+ ))}
); diff --git a/app/health/rare-disorders/components/SolutionsOffer.jsx b/app/health/rare-disorders/components/SolutionsOffer.jsx index 7ebfb26..f59ad2b 100644 --- a/app/health/rare-disorders/components/SolutionsOffer.jsx +++ b/app/health/rare-disorders/components/SolutionsOffer.jsx @@ -11,19 +11,30 @@ export default function SolutionsOffer() { ]; return ( -
-

Our Rare Disease Solutions Offer

-
+
+

Our Rare Disease Solutions Offer

+ +

+ Comprehensive genomic sequencing solutions designed to unlock genetic insights + and accelerate diagnosis for rare disease patients and their families. +

+ +
{solutions.map((sol, idx) => (
-

{sol.name}

-

{sol.desc}

+
+
+

{sol.name}

+

{sol.desc}

+
+
))}
-
+ ); } \ No newline at end of file diff --git a/app/health/rare-disorders/components/WESInfo.jsx b/app/health/rare-disorders/components/WESInfo.jsx index d9c038a..335ea25 100644 --- a/app/health/rare-disorders/components/WESInfo.jsx +++ b/app/health/rare-disorders/components/WESInfo.jsx @@ -1,22 +1,28 @@ export default function WESInfo() { + const points = [ + "Whole Exome Sequencing (WES) is recommended for individuals with unexplained genetic disorders, complex or atypical clinical presentations, or when prior genetic tests have been inconclusive.", + "It is especially valuable in diagnosing rare inherited diseases, uncovering the cause of developmental delays, intellectual disabilities, or early-onset neurological conditions, and providing insights for personalized treatment planning.", + "WES can help identify genetic causes in a wide range of rare disorders." + ]; + return ( -
-

+
+

Who Should Consider Whole Exome Sequencing (WES)?

-

- Whole Exome Sequencing (WES) is recommended for individuals with unexplained genetic - disorders, complex or atypical clinical presentations, or when prior genetic tests - have been inconclusive. -

-

- It is especially valuable in diagnosing rare inherited diseases, uncovering the cause - of developmental delays, intellectual disabilities, or early-onset neurological - conditions, and providing insights for personalized treatment planning. -

-

- WES can help identify genetic causes in a wide range of rare disorders. -

+
    + {points.map((point, idx) => ( +
  • + +

    + {point} +

    +
    • + ))} +
); } \ No newline at end of file diff --git a/app/rna-sequencing/components/AboutRNA.jsx b/app/rna-sequencing/components/AboutRNA.jsx index f67eda8..5afd5c6 100644 --- a/app/rna-sequencing/components/AboutRNA.jsx +++ b/app/rna-sequencing/components/AboutRNA.jsx @@ -4,8 +4,8 @@ import React from 'react'; const AboutRNA = () => { return (
-
-

+
+

About RNA Sequencing

@@ -16,9 +16,6 @@ const AboutRNA = () => {

RNA sequencing (RNA-Seq) is a method used to determine the sequence and quantity of RNA present in a sample, providing insight into gene expression, alternative splicing, and non-coding RNA functions. It is essential for understanding various biological processes, including disease mechanisms, gene regulation, and cellular responses.

-

- Different RNA sequencing approaches using Next-Generation Sequencing (NGS) are listed below: -

diff --git a/app/rna-sequencing/components/RNATable.jsx b/app/rna-sequencing/components/RNATable.jsx index 003d3ef..15fd452 100644 --- a/app/rna-sequencing/components/RNATable.jsx +++ b/app/rna-sequencing/components/RNATable.jsx @@ -106,7 +106,7 @@ const RNATable = () => { return (
-
+

RNA Sequencing Approaches

FeatureDescription
FeatureDescription
{feature.title} {feature.desc}
@@ -130,7 +130,7 @@ const RNATable = () => { {sequencingData.map((row, index) => ( diff --git a/public/images/icons/clock.png b/public/images/icons/clock.png new file mode 100644 index 0000000..6829e39 Binary files /dev/null and b/public/images/icons/clock.png differ diff --git a/public/images/icons/sample.png b/public/images/icons/sample.png new file mode 100644 index 0000000..5a77858 Binary files /dev/null and b/public/images/icons/sample.png differ
- + {row.approach.name}